Respiratory and Pulmonary System Respiratory Tract Infections

Table of Contents

UPCOMING PATENT EXPIRES BY THERAPY AREA
Respiratory Tract Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Respiratory Tract Infections Projects
--Bayer Ag
--Nektar Therapeutics
--OctoPlus N.V.
--Replidyne Inc
--Shionogi & Co., Ltd.
--Zeria Pharmaceutical Co., Ltd.

--Top Companies in early stage Respiratory Tract Infections Projects
--Arpida Ltd.
--Aridis Pharmaceuticals, LLC
--GlaxoSmithKline plc
--AstraZeneca Plc
--Nanotherapeutics, Inc.
--Kenta Biotech Ltd.
--Optimer Pharmaceuticals, Inc.
--Novexel
--Phynova Group PLC
--Oscient Pharmaceuticals Corp
--Vaxart, Inc.
--Sanofi-Aventis

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View